SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome. Clinics [Internet]. 2022 Jun. 13 [cited 2024 Jun. 1];77:100064. Available from: https://revistas.usp.br/clinics/article/view/213603